tiprankstipranks
Adicet Bio (GB:0HX7)
LSE:0HX7
Holding GB:0HX7?
Track your performance easily

Adicet Bio (0HX7) Income Statement

1 Followers

Adicet Bio Income Statement

Last quarter (Q3 2024), Adicet Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Adicet Bio's net income was $-30.48M. See Adicet Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 182.48M$ 714.00K$ 24.99M$ 9.73M$ 17.90M$ 995.00K
Cost of Revenue
-----$ -85.46M
Gross Profit
$ 182.12M$ 714.00K$ 704.00K$ 9.73M$ 17.90M$ 995.00K
Operating Expense
$ 128.44M$ 132.58M$ 97.54M$ 71.16M$ 57.09M$ -32.38M
Operating Income
$ -128.44M$ -152.04M$ -72.55M$ -61.43M$ -39.19M$ -31.39M
Net Non Operating Interest Income Expense
$ 10.82M$ 9.95M$ 3.68M$ -85.00K$ 651.00K$ 938.00K
Other Income Expense
$ 267.00K$ -20.04M$ -919.00K$ 606.00K$ 953.00K$ -2.33M
Pretax Income
$ -117.88M$ -142.66M$ -69.79M$ -62.12M$ -39.49M$ -28.12M
Tax Provision
---$ -125.00K$ -2.81M$ 19.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -117.88M$ -142.66M$ -69.79M$ -62.00M$ -36.68M$ -28.14M
Basic EPS
$ -1.70$ -3.31$ -1.70$ -2.00$ -5.01-
Diluted EPS
$ -1.70$ -3.31$ -1.70$ -2.00$ -5.01$ -13.15
Basic Average Shares
$ 303.83M$ 43.04M$ 41.08M$ 30.95M$ 7.32M$ 2.14M
Diluted Average Shares
$ 303.83M$ 43.04M$ 41.08M-$ 7.32M$ 2.14M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 128.44M$ 132.58M$ 97.54M$ 71.16M$ 57.09M$ 32.38M
Net Income From Continuing And Discontinued Operation
$ -117.88M$ -142.66M$ -69.79M$ -62.00M$ -36.68M$ -28.14M
Normalized Income
$ -87.51M--$ -61.05M--
Interest Expense
------
EBIT
$ -117.88M$ -142.63M$ -69.71M$ -61.95M$ -39.36M$ -28.12M
EBITDA
$ -111.31M$ -136.53M$ -67.14M$ -60.41M$ -38.13M$ -27.12M
Currency in USD

Adicet Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis